Frequently Asked Questions About Sanofi ADR (SNY) Stock
Sanofi ADR's (SNY) last reported annual revenue was USD 43.07 Billion.
Sanofi ADR's (SNY) annual revenue growth rate based on the revenue reported in the past 5 years is : 3.84%
Sanofi ADR's(SNY) is profitable as of its last reported annual financials.
The net profit margin for Sanofi ADR's(SNY) from its laster reported year is 12.54%
The return on equity (ROE) for Sanofi ADR's(SNY) from its last reported annual financials is : 7.27%
The return on assets (ROA) for Sanofi ADR's(SNY) from its last reported annual financials is : 4.54%
The return on invested capital (ROIC) for Sanofi ADR's(SNY) from its last reported annual financials is : 8.30%
The Debt to Equity ratio for Sanofi ADR's(SNY) from its last reported annual financials is : 19.38%
The dividend yield for Sanofi ADR's(SNY) from its laster reported year is 4.31%
Sanofi ADR's(SNY) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SNY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
